Immunoglobulin levels in children treated for malignant tumors
Language English Country Slovakia Media print
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
Persistent link
https://www.medvik.cz/link/pmid08289965
PubMed
8289965
Knihovny.cz E-resources
- MeSH
- Child MeSH
- Immunoglobulin A blood MeSH
- Immunoglobulin G blood MeSH
- Immunoglobulin M blood MeSH
- Immunoglobulins blood MeSH
- Infections etiology immunology MeSH
- Humans MeSH
- Kidney Neoplasms complications drug therapy immunology MeSH
- Soft Tissue Neoplasms complications drug therapy immunology MeSH
- Neoplasms complications drug therapy immunology MeSH
- Follow-Up Studies MeSH
- Lymphoma, Non-Hodgkin complications drug therapy immunology MeSH
- Neuroblastoma complications drug therapy immunology MeSH
- Antineoplastic Agents therapeutic use MeSH
- Chi-Square Distribution MeSH
- Sarcoma complications drug therapy immunology MeSH
- Wilms Tumor complications drug therapy immunology MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
- Names of Substances
- Immunoglobulin A MeSH
- Immunoglobulin G MeSH
- Immunoglobulin M MeSH
- Immunoglobulins MeSH
- Antineoplastic Agents MeSH
IgG, IgA and IgM levels were examined in children treated for different malignant tumors. Chemotherapy decreased IgG and mainly IgM. There was increased incidence of infectious complications in IgG deficiency.
